Clinical Trial Update: Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma [Phase 2]

View source ↗

Summary

Phase II trial update reporting results from gemcitabine, carboplatin, and bevacizumab in chemotherapy-naive patients with advanced or metastatic urothelial car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)
• CARBOPLATIN (Carboplatin)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Myeloproliferative Disorder, Urothelial Carcinoma | Phase 2 | Status: COMPLETED | Results posted: 2016-01-22